Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, β-endorphin, and U50, 488H administered intrathecally in the mouse

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 485-490

  Suh, H W ^a   Song, D K ^a   Choi, Y S ^a   Kim, Y H ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANTIHISTAMINIC AGENT; BETA ENDORPHIN; CYPROHEPTADINE; HISTAMINE RECEPTOR; MORPHINE; RANITIDINE; RECEPTOR SUBTYPE; THIOPERAMIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

ANIMALIA;

EID: 0029864505     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90014-1     Document Type: Article

References (24)

1. Sanuki K. The analgesic effect induced by repeated administration of histamine and histamine liberators. Jap J Pharmacol 1957; 6: 69-86.
2. Chung Y H, Miyake M, Kamei C, Tasaka K. Analgesic effect of histamine induced by intracerebral injection into mice. Agents Act 1984; 15: 137-142.
3. 2-receptors in opioid antinociception. 1989; 250: 476-484.
4. 2 receptor antagonists. Eur J Pharmacol 1992; 215: 69-74.
5. 2 receptors in the periaqueductal gray. Brain Res 1992; 588: 58-66.
6. Barke K E, Hough L B. Simultaneous measurement of opiate-induced histamine release in the periaqueductal gray and opiate antinociception: An in vivo microdialysis study. J Pharmacol Exp Ther 1993; 266: 934-942.
7. Barke K E, Hough L B. Morphine-induced increases of extracellular histamine levels in the periaqueductal grey in vivo: a microdialysis study. Brain Res 1992; 572: 146-153.
8. Suh H H, Tseng L F. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice. J Pharmacol Exp Ther 1990; 245: 587-593.
9. Suh H H, Tseng L F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice. Naunyn-Schmiedeberg's Arch Pharmacol 1990; 342: 67-71.
10. Suh H H, Tseng L F. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice. Life Sci 1990; 46: 759-765.
11. 5-enkephalin- and U50, 488H-induced analgesia in mice. Neuropharmacology 1988; 27: 957-963.
12. Suh H H, Fujimoto J M, Tseng L F. Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice. Eur J Pharmacol 1989; 168: 61-70.
13. Tseng L F, Collins K A. The tail-flick inhibition induced by beta-endorphin administered intrathecally is mediated by activation of kappa- and mu-opioid receptors in the mouse. Eur J Pharmacol 1992; 214: 59-65.
14. Tseng L F, Henneberry B, Collins K A. The antinociception induced by beta-endorphin administered intrathecally is mediated by the activation of mu- and kappa-opioid receptors in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 351: 464-468.
15. Pelissier T, Paeile C, Soto-Moyano R, Saavedra H, Hernandez A. Analgesia produced by intrathecal administration of the k opioid agonist, U50, 488H, on formalin-evoked cutaneous pain in the rat. Eur J Pharmacol 1990; 190: 287-293.
16. Endoh T, Matsnura H, Tanaka C, Nagase H. Norbinaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther 1992; 316: 30-42.
17. Broadbear J H, Negus S S, Butelman E R, de Costa B R, Woods J H. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology 1994; 115: 311-319.
18. D'Amour F E, Smith D L. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-79.
19. Hylden J L K, Wilcox G L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-316.
20. Litchfield J T, Wilcoxon F. A simplified method of evaluating dose effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
21. Tallarida L F, Murray R B. Manual of Pharmacologic Calculations with Computer Programs. New York: Springer-Verlag, 1981.
22. Nishibori M, Oishi R, Itoh Y, Saeki K. Morphine-induced changes in histamine dynamics in mouse brain. J Neurochem 1985; 45: 719-724.
23. Ioth Y, Oihsi R, Nishibori M, Sakei K. Involvement of mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J Pharmacol Exp Ther 1988; 244: 1021-1026.
24. Suzuki T, Takamoro K, Takahashi Y, Narita M, Misawa M, Onodera K. The differential effects of histamine receptor antagonists on morphine- and U-50, 488H-induced antinociception in the mouse. Life Sci 1993; 54: 203-211.